Orthofix Medical Inc. Amortization of Debt Issuance Costs
Orthofix Medical Inc. (OFIX) reported Amortization of Debt Issuance Costs of $596.00 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2016-02-29.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2016-02-29
- Orthofix Medical Inc. amortization of debt issuance costs for the quarter ending 2014-12-31 was $236.00K, a 31.11% increase year-over-year.
- Orthofix Medical Inc. amortization of debt issuance costs for the quarter ending 2014-09-30 was $128.00K, a 28.89% decline year-over-year.
- Orthofix Medical Inc. amortization of debt issuance costs for the quarter ending 2014-06-30 was $182.00K, a 1.11% increase year-over-year.
- Orthofix Medical Inc. amortization of debt issuance costs for the quarter ending 2014-03-31 was $180.00K, a 0.00% change year-over-year.
- Orthofix Medical Inc. amortization of debt issuance costs for fiscal 2015 was $596.00K, a 17.91% decline from fiscal 2014.
- Orthofix Medical Inc. amortization of debt issuance costs for fiscal 2014 was $726.00K, a 0.83% increase from fiscal 2013.
- Orthofix Medical Inc. amortization of debt issuance costs for fiscal 2013 was $720.00K, a 58.55% decline from fiscal 2012.
- Orthofix Medical Inc. amortization of debt issuance costs for fiscal 2012 was $1.74M, a 40.19% increase from fiscal 2011.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 9 month | Amortization of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2015-12-31 | $596.00K 10-K · filed 2016-02-29 | |||
| 2014-12-31 | $236.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $364.00K derived: sum of 2 quarters · filed 2016-02-29 | $546.00K derived: sum of 3 quarters · filed 2016-02-29 | $726.00K 10-K · filed 2016-02-29 |
| 2014-09-30 | $128.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-03-31 | $310.00K derived: sum of 2 quarters · filed 2015-03-31 | $490.00K 10-Q · filed 2015-03-31 | $670.00K derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | $182.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2015-03-31 | $362.00K 10-Q · filed 2015-03-31 | $542.00K derived: sum of 3 quarters · filed 2016-02-29 | $722.00K derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | $180.00K 10-Q/A · filed 2015-03-31 | $360.00K derived: sum of 2 quarters · filed 2016-02-29 | $540.00K derived: sum of 3 quarters · filed 2016-02-29 | $720.00K derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | $180.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $360.00K derived: sum of 2 quarters · filed 2016-02-29 | $540.00K derived: sum of 3 quarters · filed 2016-02-29 | $720.00K 10-K · filed 2016-02-29 |
| 2013-09-30 | $180.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-03-31 | $360.00K derived: sum of 2 quarters · filed 2015-03-31 | $540.00K 10-Q · filed 2015-03-31 | $721.00K derived: sum of 4 quarters · filed 2015-04-29 |
| 2013-06-30 | $180.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2015-03-31 | $360.00K 10-Q · filed 2015-03-31 | $541.00K derived: sum of 3 quarters · filed 2015-04-29 | $722.00K derived: sum of 4 quarters · filed 2015-04-29 |
| 2013-03-31 | $180.00K 10-Q/A · filed 2015-03-31 | $361.00K derived: sum of 2 quarters · filed 2015-04-29 | $542.00K derived: sum of 3 quarters · filed 2015-04-29 | $1.62M derived: sum of 4 quarters · filed 2015-04-29 |
| 2012-12-31 | $181.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-29 | $362.00K derived: sum of 2 quarters · filed 2015-04-29 | $1.44M derived: sum of 3 quarters · filed 2015-04-29 | $1.74M 10-K · filed 2015-04-29 |
| 2012-09-30 | $181.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-25 | $1.26M derived: sum of 2 quarters · filed 2014-03-25 | $1.56M 10-Q · filed 2014-03-25 | $1.86M derived: sum of 4 quarters · filed 2015-03-31 |
| 2012-06-30 | $1.08M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2014-03-24 | $1.38M 10-Q · filed 2014-03-24 | $1.68M derived: sum of 3 quarters · filed 2015-03-31 | $1.97M derived: sum of 4 quarters · filed 2015-03-31 |
| 2012-03-31 | $296.00K 10-Q/A · filed 2014-03-24 | $597.00K derived: sum of 2 quarters · filed 2015-03-31 | $892.00K derived: sum of 3 quarters · filed 2015-03-31 | $1.29M derived: sum of 4 quarters · filed 2015-03-31 |
| 2011-12-31 | $301.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2015-03-31 | $596.00K derived: sum of 2 quarters · filed 2015-03-31 | $990.00K derived: sum of 3 quarters · filed 2015-03-31 | $1.24M 10-K/A · filed 2015-03-31 |
| 2011-09-30 | $295.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | $689.00K derived: sum of 2 quarters · filed 2012-11-02 | $938.00K 10-Q · filed 2012-11-02 | $1.19M derived: sum of 4 quarters · filed 2014-03-24 |
| 2011-06-30 | $394.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-30 | $643.00K 10-Q · filed 2012-07-30 | $899.00K derived: sum of 3 quarters · filed 2014-03-24 | $997.00K derived: sum of 4 quarters · filed 2014-03-24 |
| 2011-03-31 | $249.00K 10-Q · filed 2012-05-04 | $505.00K derived: sum of 2 quarters · filed 2014-03-24 | $603.00K derived: sum of 3 quarters · filed 2014-03-24 | |
| 2010-12-31 | $256.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-03-24 | $354.00K derived: sum of 2 quarters · filed 2014-03-24 | $471.00K 10-K/A · filed 2014-03-24 | |
| 2010-09-30 | $98.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-31 | $215.00K 10-Q · filed 2011-10-31 | ||
| 2010-06-30 | $117.00K 10-Q · filed 2011-08-05 | |||
| 2009-12-31 | $248.00K 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |